AERx iDMS pulmonary insulin: Phase III data

Interim 12-month results from a Phase III trial of AERx iDMS pulmonary insulin showed delayed post-meal plasma glucose suppression in

Read the full 206 word article

How to gain access

Continue reading with a
two-week free trial.